Prolonged survival in a patient with hepatic malignant melanoma treated by intra-arterial bleomycin and oral hydroxyurea.
D000284:Administration, Oral; D000792:Angiography; D001706:Biopsy; D001761:Bleomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D002404:Catheterization; D002830:Choroid Neoplasms / Q000473:pathology / Q000601:surgery; D004359:Drug Therapy, Combination; D004386:Duodenum / Q000098:blood supply; D005260:Female; D006499:Hepatic Artery / Q000000981:diagnostic imaging; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage* / Q000627:therapeutic use; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery; D009362:Neoplasm Metastasis; D011379:Prognosis; D013270:Stomach / Q000098:blood supply
D001761:Bleomycin; D006918:Hydroxyurea